MIR3118-2

Q-omics provides the consensus-scored MIR3118-2 profile across patient tissues and cancer cell-line models. MIR3118-2 expression is associated with patient survival in 1 of 34 cancer types, with the highest sampling consensus in SKCM. Additionally, MIR3118-2 RNA expression shows 285 significant mutation-linked associations, with the highest sampling consensus in BRCA. Together, these results highlight SKCM, and BRCA as cancer lineages where MIR3118-2 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Survival associations

This table summarizes MIR3118-2 survival associations across molecular data types. MIR3118-2 RNA expression shows survival associations in the most cancer types (1). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

MIR3118-2 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	1	SKCM (27)	view →

This table ranks reproducible MIR3118-2 RNA expression–survival associations across cancer types. High MIR3118-2 expression shows unfavorable associations in SKCM. The SKCM Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .023). Together, the overview and detailed table identify SKCM as the clearest survival context for MIR3118-2 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	DFS	Tertile	All	0.211	0.728	.023	27	view →

Pink = unfavorable, green = favorable. all 1 lineages →

MIR3118-2-SKCM (DFS)

Explore this curve interactively →